Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 690-692, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shavali, S.
Right arrow Articles by Fukuda, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shavali, S.
Right arrow Articles by Fukuda, A.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:690-692.)
© 1999 American Association for Clinical Chemistry, Inc.

Technical Briefs

Improved Enzyme Immunoassay Method for Melatonin: Application to the Determination of Serum Melatonin in Rats, Sheep, and Humans

Shaik Shavali, Michikazu Samejimaa, Katsuhisa Uchida, Yukitomo Morita and Atsuo Fukuda

Department of Physiology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan
a author for correspondence: fax 81-53-435-2245, e-mail samejima@akiha.hama-med.ac.jp

Melatonin influences physiological processes such as reproduction (1), immune regulation (2), and aging (3). Recent findings have also indicated its potent antioxidative properties (4)(5). This hormone is known to exhibit a circadian rhythm, with high concentrations during the dark phase. Pineal function can be evaluated by the measurement of melatonin in body fluids (6)(7) by the use of specific and sensitive immunoassays.

Although RIA is widely used, Ferrua and Masseyeff (8) in 1985 first reported an immunoassay for melatonin with enzyme-labeled antibodies. They used anti-melatonin IgG coupled with horseradish peroxidase as a nonisotopic label. Although their assay procedure was simple and rapid, the detection limit of the assay was 5 pg/well, which may not be adequate to measure daytime melatonin concentrations. In 1993, Yie et al. (9) reported a competitive solid-phase enzyme immunoassay (EIA) for melatonin with melatonin-sodium-p-carboxybenzyl-alkaline phosphatase (MT-pcb-AP) as a nonisotopic label. They validated the assay with a detection limit of 1.0 fmol/well (0.2 pg/well), but the assay required overnight incubation steps over several days.

Our aim was to modify the method of Yie et al. (9) so that it could be completed within 1 or 2 days. We describe here the method and its validation in rat, sheep, and human serum samples after extraction with dichloromethane.

Polystyrene multiwell plates (modified flat bottom; Corning 25805-96), serum samples [rat (cat. no. S7648), sheep (cat. no. S2263), and human (cat. no. H1388)], bovine albumin (cat. no. A9418), thimerosal (cat. no. T8784), diethanolamine (cat. no. D8885), and melatonin (cat. no. M5250) were purchased from Sigma Chemical. MT-pcb-AP (cat. no. CIA101a) and purified anti-melatonin serum (cat. no. CIA101, lot no. S380, 24-4-89) were obtained from CIDtech Inc. The specificity of . . . [Full Text of this Article]


Acknowledgments


References






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.